Trial | A&B (drops/ml) | Device | Time (min) | FAB (ug/ml) | Device | Time (hr) | Area fraction (%) | Qualitative evaluation |
---|---|---|---|---|---|---|---|---|
1 | 0 | – | – | 20 | S | 1 | 34.305 | ++++  |
2 | 4 | S | 15 | 20 | S | 1 | 0.066 | + |
3 | 6 | L | 15 | 20 | S | 1 | 0.009 | + |
4 | 6 | S | 60 | 20 | S | 1 | 0.001 | – |
5 | 6 | L | 15 | 20 | S | 1 | 0.005 | + |
6 | 6 | L | 60 | 20 | S | 1 | 0.003 | – |
7 | 10 | S | 15 | 20 | S | 1 | 0.245 | +++ |
8 | 6 | S | 60 | 0 | – | – | 46.380 | ++++ |
9 | 6 | S | 60 | 20 | S | 1 | 0.004 | + |
10 | 6 | S | 60 | 40 | S | 1 | 0.007 | + |
11 | 6 | S | 60 | 40 | S | 18 | 0.003 | – |
12 | 6 | S | 60 | 40 | L | 1 | 0.006 | + |
13 | 6 | S | 60 | 40 | L | 18 | 0.009 | – |
14 | 6 | S | 60 | 60 | S | 1 | 0.098 | + |
15 | 6 | S | 60 | 100 | S | 1 | 0.133 | ++ |